Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancerGurubasavaraja Swamy Purawarga Matada, Sapna Vyas Bhargava, Ekta Singh et al.|Journal of Biomolecular Structure and Dynamics|2021Cited by 37
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agentGurubasavaraja Swamy Purawarga Matada, Abhishek Ghara, Prasad Sanjay Dhiwar et al.|Medicinal Chemistry Research|2021Cited by 35
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studiesI. Aayishamma, E Haripriya, Ketan R Hosamani et al.|European Journal of Medicinal Chemistry|2024Cited by 32
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief reviewPrasad Sanjay Dhiwar, Ganesh S. Andhale, Rohit Pal et al.|Journal of Biomolecular Structure and Dynamics|2023Cited by 28
An updated literature on BRAF inhibitors (2018–2023)Lalmohan Maji, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli et al.|Molecular Diversity|2023Cited by 24